Effects of antirheumatic gold compounds on the conversion of xanthine dehydrogenase to oxidase in rabbit liver cytosol in vitro

Life Sciences

Volumn 75, Issue 10, 2004, Pages 1211-1218

  Sakuma, Satoru ^a   Gotoh, Kyohko ^a   Sadatoku, Namiko ^a   Fujita, Tadashi ^a   Fujimoto, Yohko ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

Antirheumatic gold; Auranofin; Aurothioglucose; Aurothiomalate; Liver; Reactive oxygen species; Xanthine dehydrogenase; Xanthine oxidase

Indexed keywords

ACETYLCYSTEINE; AURANOFIN; AUROTHIOGLUCOSE; AUROTHIOMALATE; DIMERCAPROL; GOLD DERIVATIVE; REACTIVE OXYGEN METABOLITE; THIOMALIC ACID; XANTHINE DEHYDROGENASE; XANTHINE OXIDASE;

ANIMAL TISSUE; ARTICLE; DRUG EFFECT; ENZYME ACTIVITY; ENZYME DEGRADATION; LIVER CYTOSOL; MALE; NONHUMAN; RABBIT; TISSUE HOMOGENATE;

ANIMALS; ANTIRHEUMATIC AGENTS; AURANOFIN; AUROTHIOGLUCOSE; CELL FRACTIONATION; CYTOSOL; DOSE-RESPONSE RELATIONSHIP, DRUG; GOLD SODIUM THIOMALATE; LIVER; MALE; RABBITS; REACTIVE OXYGEN SPECIES; XANTHINE DEHYDROGENASE; XANTHINE OXIDASE;

ORYCTOLAGUS CUNICULUS;

EID: 3042683338     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2004.02.024     Document Type: Article

References (21)

1. Aaseth J., Haugen M., Forre O. Rheumatoid arthritis and metal compounds-perspectives on the role of oxygen radical detoxification. Analyst. 123(1):1998;3-6
2. Blake D.R., Stevens C.R., Sahinoglu T., Ellis G., Gaffney K., Edmonds S., Benboubetra M., Harrison R., Jawed S., Kanczler J., Millar T.M., Winyard P.G., Zhang Z. Xanthine oxidase: four roles for the enzyme in rheumatoid pathology. Biochemical Society Transactions. 25(3):1997;812-816
3. Brass C.A., Narciso J., Gollan J.L. Enhanced activity of the free radical producing enzyme xanthine oxidase in hypoxic rat liver. Regulation and pathophysiologic significance. Journal of Clinical Investigation. 87(2):1991;424-431
4. Corey E.J., Mehrotra M.M., Khan A.U. Antiarthritic gold compounds effectively quench electronically excited singlet oxygen. Science. 236(4797):1987;68-69
5. Della Corte E., Stirpe F. The regulation of xanthine oxidase. Inhibition by reduced nicotinamide-adenine dinucleotide of rat liver xanthine oxidase type D and of chick liver xanthine dehydrogenase. Biochemical Journal. 117(1):1970;97-100
6. Fujimoto Y., Sakuma S., Tagami T., Ichikawa R., Fujita T. N-Ethylmaleimide inhibits xanthine oxidase activity with no detectable change in xanthine dehydrogenase activity in rabbit liver. Life Sciences. 68(5):2000;517-524
7. Geltner D., Sternfeld M., Becker S.A., Kori M. Gold-induced ileitis. Journal of Clinical Gastroenterology. 8(2):1986;184-186
8. Gottlieb N.L. Comparison of the kinetics of parenteral and oral gold. Scandinavian Journal of Rheumatology. 51:1983;10-14
9. Harth M., Hickey J.P., Coulter W.K., Thompson J.M., Disney T.F. Gold-induced thrombocytopenia. The Journal of Rheumatology. 5(2):1978;165-172
10. Harth M., Keown P.A., Orange J.F. Monocyte dependent excited oxygen radical generation in rheumatoid arthritis: inhibition by gold sodium thiomalate. The Journal of Rheumatology. 10(5):1983;701-707
11. Hasan N.M., Cundall R.B., Adams G.E. Effects of hypoxia and reoxygenation on the conversion of xanthine dehydrogenase to oxidase in Chinese hamster V79 cells. Free Radical Biology & Medicine. 11(2):1991;170-185
12. Insel P.A. Analgesic-antipyretics and anti-inflammatory agents; drugs employed in the treatment of rheumatoid arthritis and gout. Gilman A.G., Rall T.W., Nies A.S., Taylor P. Goodman and Gilman's The Pharmacological Basis of Therapeutics. eight ed. Section IV Autacoids; Drug Therapy of Inflammation. 1990;638-681 Pergamon Press, New York
13. Kataoka K., Handa H., Nishizawa M. Induction of cellular antioxidative stress genes through heterodimeric transcription factor Nrf2/Small Maf by antirheumatic gold (I) compounds. The Journal of Biological Chemistry. 276(36):2001;34074-34081
14. Lorber A., Baumgartner W.A., Bovy R.A., Chang C.C., Hollcraft R. Clinical application for heavy metal-complexing potential of N-acetylcysteine. The Journal of Clinical Pharmacology. 13(8):1973;332-336
15. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. The Journal of Biological Chemistry. 193(1):1951;265-275
16. Miesel R., Zuber M. Elevated levels of xanthine oxidase in serum of patients with inflammatory and autoimmune rheumatic diseases. Inflammation. 17(5):1993;551-561
17. Sakuma S., Fujimoto Y., Sakamoto Y., Uchiyama T., Yoshioka K., Nishida H., Fujita T. Peroxynitrite induces the conversion of xanthine dehydrogenase to oxidase in rabbit liver. Biochemical and Biophysical Research Communications. 230(2):1997;476-479
18. Sanhueza J., Valdes J., Campos R., Garrido A., Valenzuela A. Changes in the xanthine dehydrogenase/xanthine oxidase ratio in the rat kidney subjected to ischemia-reperfusion stress: preventive effect of some flavonoids. Research Communications in Chemical Pathology and Pharmacology. 78(2):1992;211-218
19. Sharp J.T., Lidsky M.D., Duffy J., Thompson H.J., Person B.D., Masri A.F., Andrianakos A.A. Comparison of two dosage schedules of gold salts in the treatment of rheumatoid arthritis. Relationship of serum gold levels to therapeutic response. Arthritis and Rheumatism. 20(6):1977;1179-1187
20. +-dependent form (type D) to an O2-dependent form (type O). Archives of Biochemistry and Biophysics. 172(2):1976;365-379
21. Yokoyama Y., Beckman J.S., Beckman T.K. Circulating xanthine oxidase: potential mediator of ischemic injury. American Journal of Physiology. 258(1):1990;551-561